You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Ophthalmic Disease

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pulmonary Diseases, Ophthalmological Diagnostic Techniques, Artificial Intelligence Trial in Guangzhou (Ophthalmic examination,

Not yet recruiting
  • Pulmonary Diseases
  • +2 more
  • Ophthalmic examination
  • Pulmonary Examination
  • Guangzhou, Guangdong, China
    Zhongshan Ophthalmic Center, Sun Yat-sen University
May 5, 2023

Dry Eye Disease Trial (Licaminlimab ophthalmic suspension 60 mg/mL, (vehicle of Licaminlimab ophthalmic suspension))

Not yet recruiting
  • Dry Eye Disease
  • Licaminlimab ophthalmic suspension 60 mg/mL
  • placebo (vehicle of Licaminlimab ophthalmic suspension)
  • (no location specified)
May 31, 2023

Dry Eye Disease Trial in Bellaire (Topical spironolactone ophthalmic solution, 0.005 mg/cc, Placebo)

Not yet recruiting
  • Dry Eye Disease
  • Topical spironolactone ophthalmic solution, 0.005 mg/cc
  • Placebo
  • Bellaire, Texas
    Richard W Yee, MD PLLC
Aug 16, 2023

Dry Eye Syndromes Trial in Andover (IC265 Ophthalmic Solution 1%, Placebo Ophthalmic Solution (Vehicle))

Not yet recruiting
  • Dry Eye Syndromes
  • IC265 Ophthalmic Solution 1%
  • Placebo Ophthalmic Solution (Vehicle)
  • Andover, Massachusetts
    Iacta Selected Site
Aug 8, 2023

Dry Eye Disease Trial in Andover (Reproxalap Ophthalmic Solution (0.25%), Placebo Comparator)

Completed
  • Dry Eye Disease
  • Reproxalap Ophthalmic Solution (0.25%)
  • Placebo Comparator
  • Andover, Massachusetts
    Andover Eye Associates
Jan 24, 2023

Dry Eye Syndromes, Dry Eye Disease, Kerato Conjunctivitis Sicca Trial (5% Tavilermide ophthalmic solution, Vehicle ophthalmic

Not yet recruiting
  • Dry Eye Syndromes
  • +2 more
  • 5% Tavilermide ophthalmic solution
  • Vehicle ophthalmic solution
  • (no location specified)
Apr 27, 2023

Dry Eye Disease Trial in Durham (SY-201 Ophthalmic Solution 2.0%, SY-201 Ophthalmic Solution 1.0%, SY-201 Ophthalmic Solution

Recruiting
  • Dry Eye Disease
  • SY-201 Ophthalmic Solution 2.0%
  • +3 more
  • Durham, North Carolina
    Lexitas
Jul 27, 2022

Brimonidine Tartrate 0.025%/Ketotifen Fumarate 0.035%

Not yet recruiting
  • Allergic Conjunctivitis
  • rimonidine Tartrate 0.025%/Ketotifen Fumarate 0.035% Ophthalmic Solution (Combo)
  • Vehicle of brimonidine tartrate 0.025%/ketotifen fumarate 0.035% ophthalmic solution
  • (no location specified)
Apr 4, 2023

Dry Eye Disease Trial (KIO-101)

Not yet recruiting
  • Dry Eye Disease
  • (no location specified)
Nov 17, 2022

Dry Eye Trial in Mississauga (Reproxalap Ophthalmic Solution (0.25%), Xiidra® (5% lifitegrast ophthalmic solution))

Completed
  • Dry Eye
  • Reproxalap Ophthalmic Solution (0.25%)
  • Xiidra® (5% lifitegrast ophthalmic solution)
  • Mississauga, Ontario, Canada
    Cliantha Research
Sep 26, 2022

Dry Eye Disease Trial (BRM421 Ophthalmic Solution, Vehicle)

Not yet recruiting
  • Dry Eye Disease
  • (no location specified)
Jan 13, 2023

Dry Eye Disease Trial (SHJ002/Vehicle)

Not yet recruiting
  • Dry Eye Disease
  • (no location specified)
Aug 8, 2022

Dry Eye Disease Trial in Rush (INV-102, Vehicle)

Recruiting
  • Dry Eye Disease
  • Rush, New York
    iuvo BioScience
Jan 12, 2023

Cataract; Eye Disease Trial in Augusta (Novel "Snaps" Eye Shield, Standard Alcon Eye Shield)

Recruiting
  • Cataract; Eye Disease
  • Novel "Snaps" Eye Shield
  • Standard Alcon Eye Shield
  • Augusta, Georgia
    Augusta University
Jul 14, 2023

Dry Eye Trial in Raynham (Reproxalap Ophthalmic Solution (0.25%), Vehicle Ophthalmic Solution)

Completed
  • Dry Eye
  • Reproxalap Ophthalmic Solution (0.25%)
  • Vehicle Ophthalmic Solution
  • Raynham, Massachusetts
    Andover Eye Associates (Raynham)
Aug 2, 2022

Graft-versus-host-disease, Ocular Graft-versus-host Disease Trial in Bellaire (Lifitegrast 5% Ophthalmic Solution, Refresh)

Not yet recruiting
  • Graft-versus-host-disease
  • Ocular Graft-versus-host Disease
  • Lifitegrast 5% Ophthalmic Solution
  • Refresh
  • Bellaire, Texas
    Richard W Yee, MD PLLC
Apr 27, 2022

Dry Eye Syndromes Trial in Mississauga (Reproxalap Ophthalmic Solution (0.25%), Vehicle Ophthalmic Solution)

Recruiting
  • Dry Eye Syndromes
  • Reproxalap Ophthalmic Solution (0.25%)
  • Vehicle Ophthalmic Solution
  • Mississauga, Ontario, Canada
    Cliantha Research
Jun 22, 2022

Dry Eye Disease Trial (OK-101, Placebo)

Not yet recruiting
  • Dry Eye Disease
  • (no location specified)
Mar 8, 2023

Dry Eye Disease Trial (TL-925, Placebo)

Not yet recruiting
  • Dry Eye Disease
  • (no location specified)
Feb 22, 2023

Dry Eye Disease, Kerato Conjunctivitis Sicca Trial in United States (Pilocarpine Ophthalmic Topical Cream, Dose 1, Pilocarpine

Completed
  • Dry Eye Disease
  • Kerato Conjunctivitis Sicca
  • Pilocarpine Ophthalmic Topical Cream, Dose 1
  • +3 more
  • Chandler, Arizona
  • +18 more
Aug 26, 2022

Dry Eye Trial in Brecksville (Cyclosporin, Loteprednol Etabonate, Dexamethasone Ophthalmic 0.4 Mg Ophthalmic Insert)

Completed
  • Dry Eye
  • Brecksville, Ohio
    Cleveland Eye Clinic
May 9, 2022

Dry Eye Trial in Guangzhou (CsA Ophthalmic Gel, Placebo, Hypromellose Eye Drop)

Completed
  • Dry Eye
  • CsA Ophthalmic Gel
  • +2 more
  • Guangzhou, Guangdong, China
    Ophthalmological Center of Zhongshan University
Apr 21, 2022

Dry Eye Disease Trial in Memphis (Naltrexone, Placebos)

Completed
Has Results
  • Dry Eye Disease
  • Memphis, Tennessee
    Total Eye Care
Nov 16, 2022

Ocular Surface Disease Trial in Needham (Restasis)

Recruiting
  • Ocular Surface Disease
  • Needham, Massachusetts
    BostonSight
Mar 6, 2022

Dry Eye Disease Trial in United States (CequaTM (Cyclosporine 0.09%) ophthalmic solution)

Completed
  • Dry Eye Disease
  • CequaTM (Cyclosporine 0.09%) ophthalmic solution
  • Fort Myers, Florida
  • +4 more
Sep 8, 2022